Aim of this study was to compare cerebrospinal fluid (CSF) virological control, biomarkers and neurocognition of neurologically symptomatic patients on dual antiretroviral therapies (DT) versus 2NRTIs-based three-drug regimens (TT).

Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV

Trunfio, Mattia;Rugge, Walter;Mighetto, Lorenzo;Atzori, Cristiana;Nigra, Marco;Borgogno, Enrica;Guastamacchia, Giulia;Bonora, Stefano;Di Perri, Giovanni;Calcagno, Andrea
2020-01-01

Abstract

Aim of this study was to compare cerebrospinal fluid (CSF) virological control, biomarkers and neurocognition of neurologically symptomatic patients on dual antiretroviral therapies (DT) versus 2NRTIs-based three-drug regimens (TT).
2020
34
13
1899
1906
Trunfio, Mattia; Rugge, Walter; Mighetto, Lorenzo; Vai, Daniela; Atzori, Cristiana; Nigra, Marco; Domini, Simone; Borgogno, Enrica; Guastamacchia, Giulia; Bonora, Stefano; Di Perri, Giovanni; Calcagno, Andrea
File in questo prodotto:
File Dimensione Formato  
Dual CSF Trunfio AIDS 2020 postprint.pdf

Open Access dal 02/07/2021

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 582.82 kB
Formato Adobe PDF
582.82 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1749106
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 8
social impact